advertisement
11.3.4 Betablocker (8)
Showing records 1 to 8
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker22621 Effect of latanoprost and timolol on the histopathology of the human conjunctiva
Terai N; Schlötzer-Schrehardt U; Lampel J; Böhm AG; Rummelt C; Schmidt E; Pillunat LE
British Journal of Ophthalmology 2009; 93: 219-224
22802 Long-term study of nipradilol ophthalmic solution in patients with normal-tension glaucoma
Yukawa E; Nitta N; Taketani F; Matsuura T; Morishita K; Hara Y
Nippon Ganka Gakkai Zasshi 2008; 112: 994-998
22679 Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy
Liu JH; Medeiros FA; Slight JR; Weinreb RN
Ophthalmology 2009; 116: 449-454
22970 Performing meta-analysis with incomplete statistical information in clinical trials
Ma J; Liu W; Hunter A; Zhang W
BMC medical research methodology 2008; 8: 56
22862 The effect of timolol maleate on tear film break-up time in Nigerians
Fasina O; Ashaye AO; Ajayi BG
African Journal of Medicine and Medical Science 2008; 37: 43-47
22632 Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration
Karim MZ; Sawada A; Mizuno K; Kawakami H; Ishida K; Yamamoto T
Journal of Glaucoma 2009; 18: 26-31
22965 Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics
Karatas A; Sonakin O; KiliCarslan M; Baykara T
Journal of Microencapsulation 2009; 26: 63-74
22502 Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model
Stewart WC; Stewart JA; Mychaskiw MA
Eye 2009; 23: 132-140
